Woman and Man
- | Country :
- United States
- Netherlands
- | organs : -
- | Specialty : -
Extract
The purpose of this study is to evaluate the safety and efficacy of siltuximab in participants with relapsed (the return of a disease or the signs and symptoms of a disease after a period of improvement.) or refractory (cancer that does not respond to treatment) multiple myeloma (a type of cancer that begins in plasma cells [white blood cells that produce antibodies]).
Inclusion criteria
- Multiple myeloma